Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group.

18 The largest evidence in HSCT recipients with SLE demonstrated a highly significant improvement in all the 36-item Medical Outcomes Study Short-Form score domains ( Table II ), including the physical and mental component summary scores. 19 This is remarkable in view of the fact that improvements of the 36-item Medical Outcomes Study Short-Form domains in trials of targeted biologic drugs (ie, belimumab) are usually modest. 20 , 21 CD can have a negative impact on QoL. 2 Most patients with CD respond to conventional treatments and biological therapies.

also in 132,142 other papers